In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1

33Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

GITR (glucocorticoid-induced TNF receptor) is a recently identified member of the TNF receptor super-family. The receptor is preferentially expressed on CD4+CD25+ regulatory T cells and GITR signals break the suppressive activity of the subset. In this study, we wanted to reveal the in vivo function of GITR in herpes simplex virus type 1 (HSV-1) infection. A single injection of anti-GITR mAb (DTA-1) immediately after viral infection significantly increased the number of CD4+ and CD8+ T cells expressing CD25, an activation surface marker, and secreting IFN-γ. We confirmed these in vivo observations by showing ex vivo that re-stimulation of CD4+ or CD8+ T cells with a CD4+ or CD8 + T-cell-specific HSV-1 peptide, respectively, induced a significant elevation in cell proliferation and in IFN-γ secretion. Our results indicate that GITR signals play a critical role in the T-cell immunity to HSV-1.

Author supplied keywords

Cite

CITATION STYLE

APA

La, S., Kim, E., & Kwon, B. (2005). In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1. Experimental and Molecular Medicine, 37(3), 193–198. https://doi.org/10.1038/emm.2005.26

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free